Quoting Nanotech Wire:
"The U.S. Food and Drug Administration has completed a "proof-of-concept" study of a test that quickly and accurately detects the presence of even the smallest amount of the deadly anthrax toxin.
"The FDA findings could form the basis of a test that allows earlier diagnosis of anthrax infection than currently possible," said Indira Hewlett, Ph.D., the senior author of the study and chief of the Laboratory of Molecular Virology, Office of Blood Research and Review, at the FDA's Center for Biologics Evaluation and Research (CBER). "The earlier those infected with anthrax can be treated, the better.""
Read more here: